SCHEMBL24649602

SCHEMBL24649602

C/C=C\C=C(/C=C\C)CNC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18773754 1.00
SCHEMBL7937981 0.80
SCHEMBL22879505 0.80
SCHEMBL1109085 0.80
SCHEMBL20825162 0.80
SCHEMBL13824102 0.80
SCHEMBL25829096 0.78
SCHEMBL21183081 0.77
SCHEMBL16508310 0.77
SCHEMBL23172859 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348460-A1 ANTI-WOLBACHIA PYRIDO[2,3-d]PYRIMIDINECOMPOUNDS THE UNIVERSITY OF LIVERPOOL (GB) 2023-11-02 US disclosed
WO-2023133260-A2 CHEMICAL TARGETING SWI/SNF RELATED, MATRIX ASSOCIATED, ACTIN DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 4 (SMARCA4) AND USE IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) DANA-FARBER CANCER INSTITUTE, INC. (US) 2023-07-13 WO disclosed
WO-2022173743-A1 COMPOUNDS AND METHODS FOR PREVENTING, TREATING, OR AMELIORATING AIRWAY DISEASE THOMAS JEFFERSON UNIVERSITY (US) 2022-08-18 WO disclosed